Access Solutions
Moving Medicines with Purpose
Explore our Access Solutions
-
Making a locally unapproved drug available on a for-charge basis on a controlled, patient-by-patient basis, and providing guidance and support on available sources to fund treatment.
-
Supplying pharmaceutical products under contract to hospitals, NGOs and public health agencies through competitive tender processes.
-
Ensuring continuity of supply on a for-charge basis following the loss of Marketing Authorization or voluntary commercial withdrawal, allowing patients to continue treatment.
-
Delivering rapid-response pharmaceutical supply and storage solutions during public health emergencies, natural disasters or disease outbreaks, in coordination with health authorities and NGOs.
-
Providing temporary commercial supply to address product shortages using alternative country-labeled products or equivalent supply from another approved manufacturer.
-
Providing locally unapproved medical products on a free-of-charge basis for patients with serious or life-threatening conditions where no alternative is commercially available.
-
Maintaining cost-effective free-of-charge supply to clinical trial participants after trial completion, supporting trial closure and ongoing treatment requirements.
-
Providing cohort-level patient access to investigational or unapproved medicines outside of clinical trials in accordance with applicable regulatory pathways.
-
Facilitating the distribution of medical products on a free-of-charge basis for humanitarian or philanthropic purposes.
-
Supporting the importation and ongoing supply of approved medical products into commercial markets, including logistics, warehousing, order-to-cash and regulatory compliance to enable broader access.
Quality Assurance
Supply Chain & Logistics
Core Services
Pharmacovigilance
Program Management
Regulatory Compliance
Program Management
Regulatory Compliance
Pharmacovigilance
Supply Chain & Logistics
Quality Assurance
Value-Added Services
-
Strategic and tactical guidance during program evaluation and planning across all access pathways, at both product and portfolio level.
-
Operational coordination to support patient travel for treatment in approved jurisdictions, including access logistics and supply continuity where local access is not available.
-
Direct-to-patient delivery services, where permitted, supporting continuity of care through controlled, compliant last-mile distribution.
-
Regulatory guidance and operational support for artwork development, label printing, secondary labeling and packaging in line with local requirements.
-
Structured collection of patient-level safety and efficacy data to support regulatory submissions, pricing and reimbursement discussions.
-
Consultative support to sponsor medical affairs teams, providing operational input and coordination related to access programs and real-world data collection, including alignment with scientific, ethical and regulatory requirements.
-
Provision of a secure online platform to support larger access programs, enabling HCP and patient enrollment, order processing, real-world data capture and safety event reporting.
-
Strategic and tactical analysis with actionable recommendations to support pricing strategy, value positioning and funding pathways for for-charge access programs.
